CD4 and lymphopenia: For this reason, we conducted a retrospective analysis in 169 patients enrolled in the NIH ALPS-FAS cohort and documented CD4 lymphopenia (< 300 cells/μL in absence of any steroid or immunomodulant treatment) in 8 patients (4.7%, Table 1) including the above described index patient.